Delivery Order SPE2DB22D1202-SPE2DB25FVLC3
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count). This firm fixed-price delivery order, valued at $2,100.74, represents a non-set-aside competitive award and is scheduled for completion by August 28, 2025. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet units in a quantity of 30, with a ceiling value of $1,386.82. The order represents a competitively awarded, non-set-aside delivery order under a firm fixed price arrangement, with an ultimate completion date of August 25, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) with a ceiling value of $1,441.33. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, executing under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The prime contract, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 14, 2025, for Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count supply). The contract, issued under firm fixed-price terms with a ceiling value of $1,443.64, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $6,839.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count). This non-competitive delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $3,549.93 delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count unit dose packaging) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery location is specified as Conshohocken, PA, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $3,128.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablet unit dose packs (30-count) on August 5, 2025, with completion expected by August 6, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 blanket purchase agreement running through December 2026 that serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,314.14 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count packages). The contract, executed on August 18, 2025, with an ultimate completion date of August 19, 2025, is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,833.03 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,510.53 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count packages. The contract has an ultimate completion date of July 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...